See the DrugPatentWatch profile for Vocabria
What is Vocabria?
Vocabria (cabotegravir) is a prescription medicine used as part of HIV treatment. It works by blocking an enzyme HIV needs to copy itself, helping reduce the amount of HIV in the body. [1]
What is Vocabria used for?
Vocabria is used in HIV care as part of an antiretroviral regimen that includes rilpivirine (brand name: Edurant or Cabenuva, depending on the dosing setup). The goal is to control HIV by suppressing viral load. [1]
How is Vocabria taken?
Vocabria is given as an injection as part of a longer-acting treatment approach. It may be started with an oral phase or lead-in dosing strategy before switching to longer-acting injected therapy, depending on the clinical plan. [1]
How does Vocabria work compared with other HIV medicines?
Vocabria is an “integrase strand transfer inhibitor” (INSTI). This class stops HIV from inserting (integrating) its genetic material into the host cell’s DNA, a step HIV requires for replication. [1]
What side effects do people ask about?
Common side effects for medicines in this class and these injection-based regimens can include injection-site reactions (pain, swelling) and general symptoms such as headache or nausea. Patients also ask about rare but serious reactions; clinicians monitor for tolerability during treatment. [1]
Is Vocabria the same as Cabenuva?
Vocabria and Cabenuva are related but not the same product. Vocabria contains cabotegravir, while Cabenuva is a combination long-acting regimen that pairs cabotegravir with rilpivirine. In practice, Vocabria can be used as part of the process leading into or supporting cabotegravir/rilpivirine treatment. [1]
Who makes Vocabria, and where can I confirm dosing and labeling?
You can confirm the most accurate dosing instructions, warnings, and patient information in the official prescribing information and patient materials for Vocabria. [1]
---
Sources
[1] https://www.vocabria.com/